Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNSA-001 in women with diabetic gastroparesis
NCT03712124Phase 2Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Feb 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sepiapterin in diabetic gastroparesis, sponsored by PTC Therapeutics, Inc.. Started Feb 2019; status: completed.
02
Drugs
sepiapterin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT03712124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03712124.